Copyright Reports & Markets. All rights reserved.

Global Gene Therapy in Oncology Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gene Therapy in Oncology Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Ex Vivo
      • 1.4.3 In Vivo
    • 1.5 Market by Application
      • 1.5.1 Global Gene Therapy in Oncology Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Diagnostics Centers
      • 1.5.4 Research Institutes
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gene Therapy in Oncology Market Size
    • 2.2 Gene Therapy in Oncology Growth Trends by Regions
      • 2.2.1 Gene Therapy in Oncology Market Size by Regions (2014-2025)
      • 2.2.2 Gene Therapy in Oncology Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Gene Therapy in Oncology Market Size by Manufacturers
      • 3.1.1 Global Gene Therapy in Oncology Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Gene Therapy in Oncology Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gene Therapy in Oncology Key Players Head office and Area Served
    • 3.3 Key Players Gene Therapy in Oncology Product/Solution/Service
    • 3.4 Date of Enter into Gene Therapy in Oncology Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gene Therapy in Oncology Market Size by Type (2014-2019)
    • 4.2 Global Gene Therapy in Oncology Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Gene Therapy in Oncology Market Size (2014-2019)
    • 5.2 Gene Therapy in Oncology Key Players in United States
    • 5.3 United States Gene Therapy in Oncology Market Size by Type
    • 5.4 United States Gene Therapy in Oncology Market Size by Application

    6 Europe

    • 6.1 Europe Gene Therapy in Oncology Market Size (2014-2019)
    • 6.2 Gene Therapy in Oncology Key Players in Europe
    • 6.3 Europe Gene Therapy in Oncology Market Size by Type
    • 6.4 Europe Gene Therapy in Oncology Market Size by Application

    7 China

    • 7.1 China Gene Therapy in Oncology Market Size (2014-2019)
    • 7.2 Gene Therapy in Oncology Key Players in China
    • 7.3 China Gene Therapy in Oncology Market Size by Type
    • 7.4 China Gene Therapy in Oncology Market Size by Application

    8 Japan

    • 8.1 Japan Gene Therapy in Oncology Market Size (2014-2019)
    • 8.2 Gene Therapy in Oncology Key Players in Japan
    • 8.3 Japan Gene Therapy in Oncology Market Size by Type
    • 8.4 Japan Gene Therapy in Oncology Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gene Therapy in Oncology Market Size (2014-2019)
    • 9.2 Gene Therapy in Oncology Key Players in Southeast Asia
    • 9.3 Southeast Asia Gene Therapy in Oncology Market Size by Type
    • 9.4 Southeast Asia Gene Therapy in Oncology Market Size by Application

    10 India

    • 10.1 India Gene Therapy in Oncology Market Size (2014-2019)
    • 10.2 Gene Therapy in Oncology Key Players in India
    • 10.3 India Gene Therapy in Oncology Market Size by Type
    • 10.4 India Gene Therapy in Oncology Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gene Therapy in Oncology Market Size (2014-2019)
    • 11.2 Gene Therapy in Oncology Key Players in Central & South America
    • 11.3 Central & South America Gene Therapy in Oncology Market Size by Type
    • 11.4 Central & South America Gene Therapy in Oncology Market Size by Application

    12 International Players Profiles

    • 12.1 Bristol-Myers Squibb
      • 12.1.1 Bristol-Myers Squibb Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gene Therapy in Oncology Introduction
      • 12.1.4 Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2014-2019)
      • 12.1.5 Bristol-Myers Squibb Recent Development
    • 12.2 Cold Genesys
      • 12.2.1 Cold Genesys Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gene Therapy in Oncology Introduction
      • 12.2.4 Cold Genesys Revenue in Gene Therapy in Oncology Business (2014-2019)
      • 12.2.5 Cold Genesys Recent Development
    • 12.3 Advantagene
      • 12.3.1 Advantagene Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gene Therapy in Oncology Introduction
      • 12.3.4 Advantagene Revenue in Gene Therapy in Oncology Business (2014-2019)
      • 12.3.5 Advantagene Recent Development
    • 12.4 Amgen
      • 12.4.1 Amgen Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gene Therapy in Oncology Introduction
      • 12.4.4 Amgen Revenue in Gene Therapy in Oncology Business (2014-2019)
      • 12.4.5 Amgen Recent Development
    • 12.5 AstraZeneca
      • 12.5.1 AstraZeneca Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Gene Therapy in Oncology Introduction
      • 12.5.4 AstraZeneca Revenue in Gene Therapy in Oncology Business (2014-2019)
      • 12.5.5 AstraZeneca Recent Development
    • 12.6 Bio-Path Holdings
      • 12.6.1 Bio-Path Holdings Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Gene Therapy in Oncology Introduction
      • 12.6.4 Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2014-2019)
      • 12.6.5 Bio-Path Holdings Recent Development
    • 12.7 CRISPR Therapeutics
      • 12.7.1 CRISPR Therapeutics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Gene Therapy in Oncology Introduction
      • 12.7.4 CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2014-2019)
      • 12.7.5 CRISPR Therapeutics Recent Development
    • 12.8 Editas Medicine
      • 12.8.1 Editas Medicine Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Gene Therapy in Oncology Introduction
      • 12.8.4 Editas Medicine Revenue in Gene Therapy in Oncology Business (2014-2019)
      • 12.8.5 Editas Medicine Recent Development
    • 12.9 Geron Corp
      • 12.9.1 Geron Corp Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Gene Therapy in Oncology Introduction
      • 12.9.4 Geron Corp Revenue in Gene Therapy in Oncology Business (2014-2019)
      • 12.9.5 Geron Corp Recent Development
    • 12.10 Idera Pharmaceuticals
      • 12.10.1 Idera Pharmaceuticals Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Gene Therapy in Oncology Introduction
      • 12.10.4 Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2014-2019)
      • 12.10.5 Idera Pharmaceuticals Recent Development
    • 12.11 Intellia Therapeutics
    • 12.12 Johnson & Johnson
    • 12.13 Marsala Biotech
    • 12.14 Merck
    • 12.15 Mologen AG
    • 12.16 Oncolytics Biotech
    • 12.17 Oncosec
    • 12.18 Oncotelic
    • 12.19 Shenzhen SiBiono GeneTech
    • 12.20 Sillajen Biotherapeutics
    • 12.21 Tocagen
    • 12.22 UniQure
    • 12.23 Ziopharm Oncology

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient. 
      In 2018, the global Gene Therapy in Oncology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Gene Therapy in Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy in Oncology development in United States, Europe and China.

      The key players covered in this study
      Bristol-Myers Squibb
      Cold Genesys
      Advantagene
      Amgen
      AstraZeneca
      Bio-Path Holdings
      CRISPR Therapeutics
      Editas Medicine
      Geron Corp
      Idera Pharmaceuticals
      Intellia Therapeutics
      Johnson & Johnson
      Marsala Biotech
      Merck
      Mologen AG
      Oncolytics Biotech
      Oncosec
      Oncotelic
      Shenzhen SiBiono GeneTech
      Sillajen Biotherapeutics
      Tocagen
      UniQure
      Ziopharm Oncology

      Market segment by Type, the product can be split into
      Ex Vivo
      In Vivo

      Market segment by Application, split into
      Hospitals
      Diagnostics Centers
      Research Institutes

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gene Therapy in Oncology status, future forecast, growth opportunity, key market and key players.
      To present the Gene Therapy in Oncology development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gene Therapy in Oncology are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now